BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1511428)

  • 1. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR; Greaves BR; Rasberry U; Barranco SC
    Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
    Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
    Lee JH; Naito M; Tsuruo T
    Cancer Res; 1994 May; 54(9):2398-403. PubMed ID: 8162587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L; Mimnaugh EG; Myers CE; Sinha BK
    Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH; Jollow DJ; Stuart RK
    Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione as a determinant of cellular response to doxorubicin.
    Lee FY; Vessey AR; Siemann DW
    NCI Monogr; 1988; (6):211-5. PubMed ID: 3352767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA; Kang Y; Greaves B; Perry RR
    J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
    Xia H; Pinto T; Hu X; Benson PJ; Zaren HA; Gupta V; Singh S
    Cancer Res; 1996 Aug; 56(15):3495-8. PubMed ID: 8758917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
    Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of glutathione level in cultured human melanoma cells.
    Karg E; Brötell H; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(2):137-41. PubMed ID: 2564231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H
    Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.
    Andrews PA; Murphy MP; Howell SB
    Cancer Res; 1985 Dec; 45(12 Pt 1):6250-3. PubMed ID: 4063975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.